Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Infectious Diseases and Medical Microbiology
Volume 2017, Article ID 9513690, 8 pages
https://doi.org/10.1155/2017/9513690
Research Article

Diagnostic Performance of Soluble Triggering Receptor Expressed on Myeloid Cells-1 in Ventilator-Associated Pneumonia of Patients with Ischemic Stroke

1Department of Critical Care Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200001, China
2Department of Emergency Medicine, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China
3Department of Emergency Medicine, Minhang Central Hospital, School of Medicine, Fudan University, Shanghai 201100, China

Correspondence should be addressed to Rong Yin; moc.kooltuo@0002niyoreh and Jianguo Cao; moc.anis@gjcrotcod

Received 14 September 2016; Revised 26 November 2016; Accepted 20 December 2016; Published 22 February 2017

Academic Editor: Giordano Dicuonzo

Copyright © 2017 Yuetian Yu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Anand and M. H. Kollef, “The alphabet soup of pneumonia: CAP, HAP, HCAP, NHAP, and VAP,” Seminars in Respiratory and Critical Care Medicine, vol. 30, no. 1, pp. 3–9, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. C. M. Stoeppel, E. A. Eriksson, K. Hawkins et al., “Applicability of the National Healthcare Safety Network's surveillance definition of ventilator-associated events in the surgical intensive care unit: a 1-year review,” Journal of Trauma and Acute Care Surgery, vol. 77, no. 6, pp. 934–937, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Klompas, R. Branson, E. C. Eichenwald et al., “Strategies to prevent ventilator-associated pneumonia in acute care hospitals: 2014 update,” Infection Control and Hospital Epidemiology, vol. 35, no. 8, pp. 915–936, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Henriquez-Camacho and J. Losa, “Biomarkers for sepsis,” BioMed Research International, vol. 2014, Article ID 547818, 6 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Hasibeder, P. Stein, R. Brandwijk, H. Schild, and M. P. Radsak, “Evaluation and validation of the detection of soluble triggering receptor expressed on myeloid cells 1 by enzyme-linked immunosorbent assay,” Scientific Reports, vol. 5, Article ID 15381, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Wu, F. Wang, X. Fan et al., “Accuracy of plasma sTREM-1 for sepsis diagnosis in systemic inflammatory patients: a systematic review and meta-analysis,” Critical Care, vol. 16, no. 6, article no. R229, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. S. J. Palazzo, T. A. Simpson, J. M. Simmons, and L. M. Schnapp, “Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) as a diagnostic marker of ventilator-associated pneumonia,” Respiratory Care, vol. 57, no. 12, pp. 2052–2058, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. American Thoracic Society and Infectious Diseases Society of America, “Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia,” American Journal of Respiratory and Critical Care Medicine, vol. 171, no. 4, pp. 388–416, 2005. View at Publisher · View at Google Scholar
  9. I. A. Du Rand, P. V. Barber, J. Goldring et al., “British Thoracic Society guideline for advanced diagnostic and therapeutic flexible bronchoscopy in adults,” Thorax, vol. 66, supplement 3, pp. iii1–iii21, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Michel, B. Franceschini, P. Berger et al., “Early antibiotic treatment for BAL-confirmed ventilator-associated pneumonia: a role for routine endotracheal aspirate cultures,” Chest, vol. 127, no. 2, pp. 589–597, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. M. B. Schindler and P. N. Cox, “A simple method of bronchoalveolar lavage,” Anaesthesia and Intensive Care, vol. 22, no. 1, pp. 66–68, 1994. View at Google Scholar · View at Scopus
  12. H. Bayram, Ö. Tünger, M. Çivi et al., “Diagnostic and prognostic value of procalcitonin and sTREM-1 levels in sepsis,” Turkish Journal of Medical Sciences, vol. 45, no. 3, pp. 578–586, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. N. J. Anand, S. Zuick, J. Klesney-Tait, and M. H. Kollef, “Diagnostic implications of soluble triggering receptor expressed on myeloid cells-1 in BAL fluid of patients with pulmonary infiltrates in the ICU,” Chest, vol. 135, no. 3, pp. 641–647, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. G. J. Oudhuis, J. Beuving, D. Bergmans et al., “Soluble Triggering Receptor Expressed on Myeloid cells-1 in bronchoalveolar lavage fluid is not predictive for ventilator-associated pneumonia,” Intensive Care Medicine, vol. 35, no. 7, pp. 1265–1270, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Palmiere, D. Bardy, P. Mangin, and M. Augsburger, “Value of sTREM-1, procalcitonin and CRP as laboratory parameters for postmortem diagnosis of sepsis,” Journal of Infection, vol. 67, no. 6, pp. 545–555, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Horonenko, J. C. Hoyt, R. A. Robbins et al., “Soluble triggering receptor expressed on myeloid cell-1 is increased in patients with ventilator-associated pneumonia: a preliminary report,” Chest, vol. 132, no. 1, pp. 58–63, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Duflo, R. Debon, G. Monneret, J. Bienvenu, D. Chassard, and B. Allaouchiche, “Alveolar and serum procalcitonin: diagnostic and prognostic value in ventilator-associated pneumonia,” Anesthesiology, vol. 96, no. 1, pp. 74–79, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Gibot and A. Cravoisy, “Soluble form of the triggering receptor expressed on myeloid cells-1 as a marker of microbial infection,” Clinical Medicine & Research, vol. 2, no. 3, pp. 181–187, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. R. M. Determann, J. L. Millo, S. Gibot et al., “Serial changes in soluble triggering receptor expressed on myeloid cells in the lung during development of ventilator-associated pneumonia,” Intensive Care Medicine, vol. 31, no. 11, pp. 1495–1500, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Oppert, A. Reinicke, C. Müller, D. Barckow, U. Frei, and K.-U. Eckardt, “Elevations in procalcitonin but not C-reactive protein are associated with pneumonia after cardiopulmonary resuscitation,” Resuscitation, vol. 53, no. 2, pp. 167–170, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. S. J. Palazzo, T. Simpson, and L. Schnapp, “Biomarkers for ventilator-associated pneumonia: review of the literature,” Heart & Lung, vol. 40, no. 4, pp. 293–298, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. J.-X. Shi, J.-S. Li, R. Hu et al., “Diagnostic value of sTREM-1 in bronchoalveolar lavage fluid in ICU patients with bacterial lung infections: a bivariate meta-analysis,” PLoS ONE, vol. 8, no. 5, Article ID e65436, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. J. R. Delanghe and M. M. Speeckaert, “Translational research and biomarkers in neonatal sepsis,” Clinica Chimica Acta, vol. 451, pp. 46–64, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Brzozowska, P. Majak, J. Jerzyñska et al., “Exhaled nitric oxide correlates with IL-2, MCP-1, PDGF-BB and TIMP-2 in exhaled breath condensate of children with refractory asthma,” Postepy Dermatologii i Alergologii, vol. 32, no. 2, pp. 107–113, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Navratil, D. Plavec, D. Erceg, S. Bulat Lokas, J. Živković, and M. Turkalj, “Urates in exhaled breath condensate as a biomarker of control in childhood asthma,” Journal of Asthma, vol. 52, no. 5, pp. 437–446, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Tahan, H. H. Akar, and B. Saraymen, “Exhaled breath condensate annexin A5 levels in exercise-induced bronchoconstriction in asthma: a preliminary study,” Allergologia et Immunopathologia, vol. 43, no. 6, pp. 538–542, 2015. View at Publisher · View at Google Scholar · View at Scopus